No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
DNTH241220C17500
- 0.00
- 0.000.00%
15min DelayClose Dec 20 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest17.50Strike Price0.00Turnover0.00%IV-26.47%PremiumDec 20, 2024Expiry Date6.30Intrinsic Value100Multiplier-1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma3.69Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
No Data
News
Forecasting The Future: 5 Analyst Projections For Dianthus Therapeutics
TD Cowen Initiates Dianthus Therapeutics(DNTH.US) With Buy Rating
TD Cowen Initiates Coverage on Dianthus Therapeutics With Buy Rating
Stifel Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating, Raises Target Price to $52
Powell Industries Reports Weak Sales, Joins Target, QuidelOrtho And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Oppenheimer Initiates Dianthus Therapeutics(DNTH.US) With Buy Rating, Announces Target Price $52